Omvoh: Bowel disease drug gets US FDA approval
- 27-Oct-2023
Eli Lilly and Co said on Thursday that the U.S. health regulator had approved Omvoh, its drug for treating adults with moderate-to-severe active ulcerative colitis, a type of chronic inflammatory bowel disease. The drug, which will be available in the United States in coming weeks and sold under brand name Omvoh, is among Lilly’s potential […]